Mirae Asset Global Etfs Holdings Ltd. Nuvalent, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,822 shares of NUVL stock, worth $2.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,822
Previous 31,047
0.72%
Holding current value
$2.38 Million
Previous $2.43 Million
10.08%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.39 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$407 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$343 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$233 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$143 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.32B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...